PlainRecalls
FDA Drug Moderate Class II Terminated

Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20

Reported: July 16, 2014 Initiated: May 16, 2014 #D-1424-2014

Product Description

Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20

Reason for Recall

Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution

Details

Recalling Firm
Hospira Inc.
Units Affected
45,448 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20. Recalled by Hospira Inc.. Units affected: 45,448 vials.
Why was this product recalled?
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
Which agency issued this recall?
This recall was issued by the FDA Drug on July 16, 2014. Severity: Moderate. Recall number: D-1424-2014.